Vaccine Therapy in Treating Patients With Acute Myeloid Leukemia

Stopped Protocol is withdrawn due to inadequate accrual

Conditions

• Leukemia

Interventions

• DRUG: autologous tumor cell vaccine
• DRUG: therapeutic autologous dendritic cells
• PROCEDURE: tumor cell-derivative vaccine therapy

Sponsor

Boston Medical Center